Anaptysbio ANAB
NASDAQ ANAB
$48.63 -1.63 (-3.24%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anaptysbio (ANAB) EV to FCF (2021 - 2026)

Updated

Anaptysbio's EV to FCF came in at 178.46 for Q1 2026, up 489.2% from the prior quarter.

Analysis

Anaptysbio (ANAB) EV to FCF (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Mar 31, 2026, Anaptysbio reported EV to FCF of -8.96; for FY2025, it was 30.29.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Anaptysbio 1.46 Bn 346.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 178.46
Dec 31, 2025 30.29
Sep 30, 2021 8.00
Jun 30, 2021 15.53
API Access

Anaptysbio EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=ANAB&period=max&api_key=YOUR_API_KEY